Key considerations for the clinical management of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) episode artwork

EPISODE · Mar 23, 2023 · 36 MIN

Key considerations for the clinical management of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD)

from touchPODCAST · host touchPODCAST

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a radiologist, a nephrologist and a primary care physician discuss how to predict progression and prognosis in ADPKD, as well as current and emerging treatment options for rapidly progressing disease, and how to manage potential side effects.  The experts: Prof. Bradley Erickson, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Prof. Neera Dahl, Yale University, Yale School of Medicine, New Haven, CT, USA; Prof. Charles Vega, UCI Health, Santa Ana, CA, USA This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted independent medical educational grant from Otsuka America Pharmaceutical, Inc. This activity is jointly provided by USF Health and touchIME.  For further information please visit: https://touchendocrinologyime.org/clinical-management-of-rapidly-progressing-ADPKD

Episode metadata supplied by the publisher feed · Published Mar 23, 2023

Embed this episode

Ready to play

Key considerations for the clinical management of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD)

0:00 36:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 36 minutes long.

When was this touchPODCAST episode published?

This episode was published on March 23, 2023.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!